Stanford ChEM-H scientists propose a new hypothesis for how bacterial assembly lines produce an important class of drugs, potentially helping scientists generate novel drugs including new types of antibiotics.
Polly Fordyce, currently a postdoctoral fellow at the University of California, San Francisco, will be joining Stanford as assistant professor of genetics, bringing a background in physics, biology and biochemistry to her studies of how proteins interact with DNA and how diseases arise when those...
Stanford’s new Center of Excellence for Translation Research will focus on ushering potential antiviral therapies from bench to bedside.
“As a physician-scientist, there is nothing more exciting and motivating than to translate basic science discoveries in my laboratory into potential new therapies...
Carolyn Bertozzi, who for the past 18 years has been on the faculty at the University of California, Berkeley, will be joining Stanford as professor of chemistry and, by courtesy, of chemical and systems biology starting April, 2015.
Given a year to mature, the Institute for Chemical Biology is relaunching under a new name that better reflects its vision of bringing Stanford's unique interdisciplinary culture to bear at a new frontier of chemistry.
A team of scientists including SICB member Michael Lin invented tools for watching mice brain nerves send signals in real time. The technique will make it easier to study brain functions and help develop therapies for brain diseases.
In his annual address to the Academic Council, President John Hennessy emphasized the success of Stanford's interdisciplinary institutes including SICB and recognized faculty excellence as he outlined university advancements over the past academic year.
How do embryos form the cells in our lungs, muscles, nerves and other tissues? A new process decodes the genetic instructions that enable the all-purpose cells of the embryo to multiply and transform into the many specialized cell types in the body.
BY AMY ADAMS
Stanford recently announced two new institutes that bridge departmental and school boundaries — the Stanford Neurosciences Institute and the Stanford Institute for Chemical Biology — bringing the number of university-wide interdisciplinary laboratories, centers and institutes on campus...
BY TOM ABATE
Neuroscientists and bioengineers at Stanford are working together to solve a mystery: How does nature construct the different types of synapses that connect neurons, the cells that monitor nerve impulses, control muscles and form thoughts?
Stanford's Folding@home project, run by Institute for Chemical Biology member Vijay Pande, has tapped the processing power of 200,000 computers to simulate the structure of a protein that allows cancer cells to run amok. The work could assist the design of new drugs that specifically target this...
A team of scientists including Institute for Chemical Biology member Alex Dunn has found the secret to how nerves withstand the wear and tear of bending joints and moving tissues: an elastic-like protein matrix that keeps them resilient.
Cross-discipline research that began with campus newts has led to discovery of a way to highlight the location of pain in a living animal. This workby a team including Institute for Chemical Biology Exective Committee member Justin DuBois could one day produce a new type of drug for treating pain...
The successful atom-level simulation of a G protein-coupled receptor by Institute for Chemical Biology member Vijay Pande could lead to improved drug design, blazing the path for specialized scientific projects on cloud computer systems.
By Bruce Goldman
Peter S. Kim, who for the past decade has served as president of Merck Research Laboratories, will join the Stanford University School of Medicine faculty as a professor of biochemistry.
"I'm thrilled to come back to Stanford," said Kim, 55, who earned a PhD in biochemistry here in...